StockData
IXHLNasdaqPharmaceutical PreparationsFiscal year ends June 30

Incannex Healthcare Inc.

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 25, 2026
$2.76−0.06 (-2.13%)

Close on Oct 19, 2026

Market cap
$33.89M
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2022
Ended Dec 31, 2021
Mar 21, 2022Before market open–––

Press releases

Announcements Incannex Healthcare filed with the SEC